Five Republican Senators have reintroduced a bill to bar the federal government from undertaking comparative effectiveness research, according to a release by Senator Mike Crapo (R-Idaho). The 2009 ...

Comparative effectiveness research (CER), which helps payers determine plan coverage options based on the effectiveness of certain treatments, could improve the entire healthcare industry, according ...

This is a comparative effectiveness study that evaluates the safety effects of 2 types of commercially available electronic prescribing systems. The increasingly widespread adoption of electronic ...

“Are we going to throw expensive treatment at someone who is going to die anyway? How do we get people to accept that more isn’t always better, the newest treatment isn’t always better?” Those were ...

If there was one place research should be easy to perform, it’s on a disease that’s incredibly common. Further, if there are two generally-accepted strategies to treating symptomatic patients with ...

The healthcare industry is taking note as CER continues to evolve. This industry keeps evolving, and this evolution defines the relationships between the pharmaceutical industry and its customers; in ...

Comparative effectiveness research has been the target of recurrent criticism in some political circles, with opponents claiming it’s the “gateway to rationing” or it encourages “cookbook medicine.” ...

The goal of comparative effectiveness research is to inform clinical decisions between alternate treatment strategies using data that reflect real patient populations and real-world clinical scenarios ...

The research results must avoid creating unintended access barriers, coverage denials, or arbitrary dollar thresholds that can arise through centralized cost effectiveness determinations. By focusing ...

Comparative effectiveness research is under attack as a new way to limit access to the best health care. Nothing could be further from the truth—in fact, it’s the exact opposite. Comparative ...

A Comparative Effectiveness Research (CER) study shows that surgery is better than medical treatment for a particular cardiac condition. My patient is 78 years old and has complicated diabetes. – does ...

In the article that accompanies this editorial, Lu et al 5 conducted a systematic review on the use of instrumental variable (IV) methods in oncology comparative effectiveness research. The main ...